Evidence map›Paper›PMID 28938953›Full record

ArticleKidney international2017

Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Ségolène Aymé, Detlef Bockenhauer, Simon Day, Olivier Devuyst, Lisa M Guay-Woodford, Julie R Ingelfinger, Jon B Klein, Nine V A M Knoers, Ronald D Perrone, Julia Roberts and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Kidney international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. The Role of Genetic Testing in Adult CKD.Journal of the American Society of Nephrology : JASN · 2024
    Article
  9. Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research.Journal of the American Society of Nephrology : JASN · 2024
    Article
  10. Rare Kidney Diseases: Children Being Left Out in the Cold.Clinical journal of the American Society of Nephrology : CJASN · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  16. A practical approach to the genomics of kidney disorders.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Ségolène AyméInstitut du Cerveau et de la Moelle Épinière, Centre National de la Recherche Scientifique Unite Mixte de Recherche 7225, Institut National de la Santé et de la Recherche Médicale U 1127, Université Pierre et Marie Curie-P6 Unite Mixte de Recherche S 1127, Paris, France.
Detlef BockenhauerUniversity College of London Centre for Nephrology, Great Ormond Street Hospital for Children National Health Service Foundation Trust, London, UK.
Simon DayClinical Trials Consulting and Training Limited, Buckingham, UK.
Olivier DevuystInstitute of Physiology, University of Zurich, Zurich, Switzerland. Electronic address: olivier.devuyst@uzh.ch.
Lisa M Guay-WoodfordCenter for Translational Science, Children's National Health System, Washington, DC, USA. Electronic address: LGuaywoo@childrensnational.org.
Julie R IngelfingerMassGeneral Hospital for Children at Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA.
Jon B KleinDivision of Nephrology and Hypertension, The University of Louisville School of Medicine, Louisville, Kentucky, USA.
Nine V A M KnoersDepartment of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Ronald D PerroneDepartment of Medicine, Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.
Julia RobertsPolycystic Kidney Disease Foundation, Kansas City, Missouri, USA.
Franz SchaeferDivision of Pediatric Nephrology, Centre for Pediatrics and Adolescent Medicine, Heidelberg University Medical Centre, Heidelberg, Germany.
Vicente E TorresDivision of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Michael CheungKidney Disease: Improving Global Outcomes, Brussels, Belgium.
David C WheelerUniversity College London, London, UK.
Wolfgang C WinkelmayerSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Conference Participants

Funding

Pilot and FeasibilityP30DK090728 · NIDDK · MAYO CLINIC ROCHESTER · PI TORRES, VICENTE E · 2010 to 2019
$11.8M
RENIN ANGIOTENSIN SYSTEM IN THE PATHOGENESIS OF ADPKDR01DK044863 · NIDDK · MAYO CLINIC ROCHESTER · PI TORRES, VICENTE E · 1991 to 2019
$4.5M
NIDDK NIH HHS P30 DK090728NIDDK NIH HHS R01 DK044863
6 · The paper itself

Abstract

Rare kidney diseases encompass at least 150 different conditions, most of which are inherited. Although individual rare kidney diseases raise specific issues, as a group these rare diseases can have overlapping challenges in diagnosis and treatment. These challenges include small numbers of affected patients, unidentified causes of disease, lack of biomarkers for monitoring disease progression, and need for complex care. To address common clinical and patient issues among rare kidney diseases, the KDIGO Controversies Conference entitled, Common Elements in Rare Kidney Diseases, brought together a panel of multidisciplinary clinical providers and patient advocates to address five central issues for rare kidney diseases. These issues encompassed diagnostic challenges, management of kidney functional decline and progression of chronic kidney disease, challenges in clinical study design, translation of advances in research to clinical care, and provision of practical and integrated patient support. Thus, by a process of consensus, guidance for addressing these challenges was developed and is presented here.

Indexed as

BiomarkersCongresses as TopicConsensusDisease ProgressionGlomerular Filtration RateHumansInterdisciplinary CommunicationKidneyKidney DiseasesNephrologistsNephrologyPatient Care TeamPractice Guidelines as TopicPrevalenceRare DiseasesBiomarkerschronic kidney disease progressionclinical trialsdiagnosticsgenetic kidney diseasespractical and integrated patient supporttranslational care

Identifiers

PMID28938953
PMCPMC6685068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.